Patent US3961038A successfully refreshed from Google Patents.
US3961038A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the manufacture of injectable preparations of Tc99m and/or In113m and apparatus for carrying out the process
Assignee: ICN Switzerland AG
•
Filing: 1973-05-07
•
Granted: 1976-06-01
•
Expires: 1993-05-07
Abstract
Abstract Process for preparing injectable technetium-99m or indium-113m preparation of high specific activity by contacting an aqueous solution of such radionuclide of low specific activity with a metal hydroxide precipitate, separating the precipitate with the radionuclide concentrated therein and dissolving the precipitate in an aqueous solution of a chelating agent.
Inventors
- 👤 Ivan Benes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 13:01
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/12; A61K51/1241; A61K51/02; A61K51/04; A61K51/0474; A61K51/0478; A61K2123/00
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
98 words
Process for preparing an injectable preparation of a radionuclide selected from the group consisting of technetium-99m and indium-113m of high specific activity per volume, which comprises contacting an aqueous solution of the radionuclide of low specific activity per volume with a sparingly water-soluble metal hydroxide precipitate, separating the metal hydroxide precipitate, with the radionuclide concentrated therein, from the aqueous solution, and dissolving said metal hydroxide precipitate in an aqueous solution containing a dissolved compound capable of forming a stable and physiologically acceptable chelate with the metal ions of the metal hydroxide to form a chelate of the metal.
Claim 2
Dependent Claim
98 words
Process for preparing an injectable preparation of a radionuclide selected from the group consisting of technetium-99m and indium-113m of high specific activity per volume, which comprises contacting an aqueous solution of the radionuclide of low specific activity per volume with a sparingly water-soluble metal hydroxide precipitate, separating the metal hydroxide precipitate, with the radionuclide concentrated therein, from the aqueous solution, and dissolving said metal hydroxide precipitate in an aqueous solution containing a dissolved compound capable of forming a stable and physiologically acceptable chelate with the metal ions of the metal hydroxide to form a chelate of the metal.
Claim 3
Dependent Claim
53 words
Process according to claim 1, wherein the metal hydroxide precipitate is produced in the solution of low specific activity per volume by adding a water-soluble salt of the metal to the solution and adding an aqueous alkaline solution to the resultant solution in an amount sufficient to cause prpecipitation precipitation the metal hydroxide.
Claim 4
Dependent Claim
25 words
Process according to claim 1, wherein the solution of low specific activity is mixed directly with the metal hydroxide precipitate which has been previously prepared.
Claim 5
Dependent Claim
22 words
Process according to claim 1, wherein the metal hydroxide precipitate is an iron hydroxide, calcium hydroxide, magnesium hydroxide or aluminum hydroxide precipitate.
Claim 6
Dependent Claim
36 words
Process according to claim 1, wherein the separated metal hydroxide precipitate is dissolved in an aqueous solution of the chelating agent and at least one acid selected from the group consisting of inorganic and organic acids.
Claim 7
Dependent Claim
13 words
Process according to claim 5, wherein the organic acid is a chelating agent.
Claim 8
Dependent Claim
17 words
Process according to claim 6, wherein the organic acid is ascorbic acid, citric acid or lactic acid.
Claim 9
Dependent Claim
14 words
Process according to claim 5, wherein the acid is hydrochloric acid or acetic acid.
Claim 10
Dependent Claim
17 words
Process according to claim 5, wherein the chelating agent is an aminopolycarboxylic acid or a salt thereof.
Claim 11
Dependent Claim
19 words
Process according to claim 9, wherein the chelating agent is the ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid or a salt thereof.
Claim 12
Dependent Claim
22 words
Process according to claim 1, wherein the solution containing the separated metal hydroxide precipitate is mixed with an aqueous buffer system solution.
Claim 13
Dependent Claim
21 words
Process according to claim 11, wherein the buffer system solution is a citrate, mixed citrate-phosphate or tris (hydroxymethyl) aminoethane buffer solution.
Claim 14
Dependent Claim
22 words
Process according to claim 11, wherein a mixed solution of the chelating agent and the buffer is used for the chelate formation.
Claim 15
Dependent Claim
23 words
Process according to claim 1, wherein the starting materials and solutions are sterile and the process is carried out under sterile conditions throughout.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-06-01 | 1979-12-01 | 1980-06-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-06-01 | 1983-12-01 | 1984-06-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-06-01 | 1987-12-01 | 1988-06-01 | $7700.00 | Window Closed / Lapsed |